UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 546

Sortiert nach

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

British journal of cancer, 2005-02, Vol.92 (3), p.480-487

2005

Volltextzugriff (PDF)

Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2 : A novel co-substrate-mediated antitumor prodrug therapy

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (15), p.4179-4186

2000

Volltextzugriff (PDF)

Antibody-Enzyme Conjugates for Cancer Therapy

JNCI : Journal of the National Cancer Institute, 1996-02, Vol.88 (3-4), p.153-165

1996

Volltextzugriff (PDF)

A cytotoxic agent can be generated selectively at cancer sites

British journal of cancer, 1988-12, Vol.58 (6), p.700-703

1988

Volltextzugriff (PDF)

Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase

Biochemical pharmacology, 1995-08, Vol.50 (5), p.609-618

1995

Volltextzugriff (PDF)

Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185

Cancer research (Chicago, Ill.), 1994-10, Vol.54 (19), p.5171-5177

1994

Volltextzugriff (PDF)

Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody

British journal of cancer, 1996-03, Vol.73 (5), p.565-572

1996

Volltextzugriff (PDF)

Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody

British journal of cancer, 1995, Vol.71 (1), p.18-24

1995

Volltextzugriff (PDF)

ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts

Cancer research (Chicago, Ill.), 1996-07, Vol.56 (14), p.3287-3292

1996

Volltextzugriff (PDF)

Control Laws for Minimum Orbital Change-The Satellite Retrieval Problem

Journal of guidance, control, and dynamics, 2001-11, Vol.24 (6), p.1231-1233

2001

Volltextzugriff (PDF)

Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs

British journal of cancer, 1995-11, Vol.72 (5), p.1083-1088

1995

Volltextzugriff (PDF)

Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy

Gene therapy, 1996-12, Vol.3 (12), p.1143

1996

Volltextzugriff (PDF)

Optimization of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2

Journal of immunological methods, 1993-01, Vol.158 (1), p.49-56

1993

Volltextzugriff (PDF)

New Mustard Prodrugs for Antibody-Directed Enzyme Prodrug Therapy: Alternatives to the Amide Link

Journal of medicinal chemistry, 1996-03, Vol.39 (5), p.1100-1105

1996

Volltextzugriff (PDF)

The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I: Purification and properties of a nitroreductase enzyme from Escherichia coli—A potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)

Biochemical pharmacology, 1992-12, Vol.44 (12), p.2289-2295

1992

Volltextzugriff (PDF)

Galactosylated antibodies and antibody‐enzyme conjugates in antibody‐directed enzyme prodrug therapy

Cancer, 1994-02, Vol.73 (S3), p.1114-1120

1994

Volltextzugriff (PDF)

Sensitivity effects on distributed-effect optical sensor output

Journal of sound and vibration, 1996-11, Vol.198 (1), p.123-130

1996

Volltextzugriff (PDF)

Virtual cofactors for an Escherichia coli nitroreductase enzyme: Relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT)

Biochemical pharmacology, 1995-05, Vol.49 (11), p.1641-1647

1995

Volltextzugriff (PDF)

Disposition of the prodrug 4-( (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice

British journal of cancer, 1990-12, Vol.62 (6), p.909-914

1990

Volltextzugriff (PDF)

Antibody directed enzyme prodrug therapy (ADEPT): clinical report

Disease markers, 1991-05, Vol.9 (3-4), p.233

1991

Volltextzugriff (PDF)

Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT

Transplantation proceedings, 1996-12, Vol.28 (6), p.3154-3155

1996

Volltextzugriff (PDF)

The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—II: A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase

Biochemical pharmacology, 1992-12, Vol.44 (12), p.2297-2301

1992

Volltextzugriff (PDF)

Performance of Optical Sensors in the Control of Flexible Structures

Journal of intelligent material systems and structures, 1997-11, Vol.8 (11), p.920-928

1997

Volltextzugriff (PDF)

Developments with targeted enzymes in cancer therapy

Current Opinion in Immunology, 1999-10, Vol.11 (5), p.579-583

1999

Volltextzugriff (PDF)

Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease

Biochemical Society transactions, 1995-11, Vol.23 (4), p.1047

1995

Volltextzugriff (PDF)

1 – 25 von 546

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(500)
Mit Volltextzugriff
(428)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2 : A novel co-substrate-mediated antitumor prodrug therapy

Antibody-Enzyme Conjugates for Cancer Therapy

A cytotoxic agent can be generated selectively at cancer sites

Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase

Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185

Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody

Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody

ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts

Control Laws for Minimum Orbital Change-The Satellite Retrieval Problem

Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs

Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy

Optimization of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2

New Mustard Prodrugs for Antibody-Directed Enzyme Prodrug Therapy: Alternatives to the Amide Link

The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I: Purification and properties of a nitroreductase enzyme from Escherichia coli—A potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)

Galactosylated antibodies and antibody‐enzyme conjugates in antibody‐directed enzyme prodrug therapy

Sensitivity effects on distributed-effect optical sensor output

Virtual cofactors for an Escherichia coli nitroreductase enzyme: Relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT)

Disposition of the prodrug 4-( (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice

Antibody directed enzyme prodrug therapy (ADEPT): clinical report

Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT

The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—II: A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase

Performance of Optical Sensors in the Control of Flexible Structures

Developments with targeted enzymes in cancer therapy

Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease

Suchergebnisse filtern